Physicians' Academy for Cardiovascular Education

Diabetes & CVD: Time for a multifactorial approach

10' education - Aug. 27, 2018 - ESC 2018 - Munich, Germany - John E Deanfield, MD - London, United Kingdom - Online CME

In recent years, new insights into the CV risk associated with diabetes have resulted in a new management approach of T2DM. Prof. Deanfield explains the rationale of a multifactorial approach.

Video navigation menu

  • Diabetes is associated with substantial CV risk, which is already present before diagnosis 0:25
  • Management of diabetes and the associated CV risk requires a multifactorial approach 2:57
  • How should CV risk reduction in diabetes be approached? 4:46
  • Too intensive glucose-lowering therapy may cause harm 7:14
  • New strategies to lower blood glucose have turned out to be real game changers 8:25

Educational information

This lecture was part of a CME accredited symposium: "Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?", held during ESC 2018 in Munich, Germany.


Prof John E Deanfield, MD - cardiologist, University College London, London, UK


This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.


Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk.

View slides of prof. Deanfield


This is available as accredited online CME for members. Click the button below to enroll:

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: